CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation.
Publication
, Journal Article
Ciobanu, N; Runowicz, CD; Wiernik, PH; Strauman, T; Sheridan, C; Bast, RC
Published in: American journal of obstetrics and gynecology
February 1989
Levels of CA 125, determined in three patients with ovarian carcinoma undergoing autologous bone marrow transplantation, dropped significantly in the month after bone marrow transplantation. This decrease was linear by multiple regression analysis. The CA 125 decrease after bone marrow transplantation in patients with nonevaluable or stable disease may represent biologic response to high-dose therapy.
Duke Scholars
Published In
American journal of obstetrics and gynecology
DOI
EISSN
1097-6868
ISSN
0002-9378
Publication Date
February 1989
Volume
160
Issue
2
Start / End Page
354 / 355
Related Subject Headings
- Ovarian Neoplasms
- Obstetrics & Reproductive Medicine
- Middle Aged
- Humans
- Female
- Bone Marrow Transplantation
- Antigens, Tumor-Associated, Carbohydrate
- Adult
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Ciobanu, N., Runowicz, C. D., Wiernik, P. H., Strauman, T., Sheridan, C., & Bast, R. C. (1989). CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation. American Journal of Obstetrics and Gynecology, 160(2), 354–355. https://doi.org/10.1016/0002-9378(89)90442-0
Ciobanu, N., C. D. Runowicz, P. H. Wiernik, T. Strauman, C. Sheridan, and R. C. Bast. “CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation.” American Journal of Obstetrics and Gynecology 160, no. 2 (February 1989): 354–55. https://doi.org/10.1016/0002-9378(89)90442-0.
Ciobanu N, Runowicz CD, Wiernik PH, Strauman T, Sheridan C, Bast RC. CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation. American journal of obstetrics and gynecology. 1989 Feb;160(2):354–5.
Ciobanu, N., et al. “CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation.” American Journal of Obstetrics and Gynecology, vol. 160, no. 2, Feb. 1989, pp. 354–55. Epmc, doi:10.1016/0002-9378(89)90442-0.
Ciobanu N, Runowicz CD, Wiernik PH, Strauman T, Sheridan C, Bast RC. CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation. American journal of obstetrics and gynecology. 1989 Feb;160(2):354–355.
Published In
American journal of obstetrics and gynecology
DOI
EISSN
1097-6868
ISSN
0002-9378
Publication Date
February 1989
Volume
160
Issue
2
Start / End Page
354 / 355
Related Subject Headings
- Ovarian Neoplasms
- Obstetrics & Reproductive Medicine
- Middle Aged
- Humans
- Female
- Bone Marrow Transplantation
- Antigens, Tumor-Associated, Carbohydrate
- Adult
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine